BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 34611764)

  • 21. Rhabdoid tumor predisposition syndrome.
    Sredni ST; Tomita T
    Pediatr Dev Pathol; 2015; 18(1):49-58. PubMed ID: 25494491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brachyury expression in intracranial SMARCB1-deficient tumors: important points for distinguishing poorly differentiated chordoma from atypical teratoid/rhabdoid tumor.
    Kohashi K; Yamamoto H; Yamada Y; Kinoshita I; Oda Y
    Hum Pathol; 2021 Jun; 112():1-8. PubMed ID: 33741347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of TEAD4 in atypical teratoid/rhabdoid tumor: New insight to the pathophysiology of an aggressive brain tumor.
    Suzuki M; Kondo A; Ogino I; Arai H; Tomita T; Sredni ST
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27966820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study.
    Dufour C; Beaugrand A; Le Deley MC; Bourdeaut F; André N; Leblond P; Bertozzi AI; Frappaz D; Rialland X; Fouyssac F; Edan C; Grill J; Quidot M; Varlet P
    Cancer; 2012 Aug; 118(15):3812-21. PubMed ID: 22180295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical Teratoid/Rhabdoid Tumor (AT/RT) Arising From Ependymoma: A Type of AT/RT Secondarily Developing From Other Primary Central Nervous System Tumors.
    Nobusawa S; Hirato J; Sugai T; Okura N; Yamazaki T; Yamada S; Ikota H; Nakazato Y; Yokoo H
    J Neuropathol Exp Neurol; 2016 Feb; 75(2):167-74. PubMed ID: 26769252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atypical teratoid/rhabdoid tumor of the central nervous system: clinico-pathological study.
    Lee MC; Park SK; Lim JS; Jung S; Kim JH; Woo YJ; Lee JS; Kim HI; Jeong MJ; Choi HY
    Neuropathology; 2002 Dec; 22(4):252-60. PubMed ID: 12564764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reclassification of rhabdoid tumor and pediatric undifferentiated/unclassified sarcoma with complete loss of SMARCB1/INI1 protein expression: three subtypes of rhabdoid tumor according to their histological features.
    Kohashi K; Tanaka Y; Kishimoto H; Yamamoto H; Yamada Y; Taguchi T; Iwamoto Y; Oda Y
    Mod Pathol; 2016 Oct; 29(10):1232-42. PubMed ID: 27338635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two Cases of Atypical Teratoid/Rhabdoid Tumor in the Spinal Cord: Loss of SMARCB1 in a Child and Loss of SMARCA4 in an Adult.
    Morisako T; Umebayashi D; Nagai T; Yamanaka T; Hirose T; Shishido-Hara Y; Konishi E; Hashimoto N
    NMC Case Rep J; 2024; 11():27-32. PubMed ID: 38410173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical teratoid rhabdoid tumors (ATRTs): the British Columbia's Children's Hospital's experience, 1986-2006.
    Fleming AJ; Hukin J; Rassekh R; Fryer C; Kim J; Stemmer-Rachamimov A; Birks DK; Huang A; Yip S; Dunham C
    Brain Pathol; 2012 Sep; 22(5):625-35. PubMed ID: 22188464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation.
    Fujisawa H; Misaki K; Takabatake Y; Hasegawa M; Yamashita J
    J Neurooncol; 2005 Jun; 73(2):117-24. PubMed ID: 15981100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atypical teratoid/rhabdoid tumor of the central nervous system: clinicopathologic and immunohistochemical features of four cases.
    Ertan Y; Sezak M; Turhan T; Kantar M; Erşahin Y; Mutluer S; Vergin C; Oniz H; Akalin T
    Childs Nerv Syst; 2009 Jun; 25(6):707-11. PubMed ID: 19212771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology.
    Ramalingam P; Croce S; McCluggage WG
    Histopathology; 2017 Feb; 70(3):359-366. PubMed ID: 27656868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic Alterations in Undifferentiated Malignant Tumors with Rhabdoid Phenotype and Loss of BRG1 Immunoexpression Identified by Fine Needle Aspirates.
    Mei L; Alikhan M; Mujacic I; Parilla M; Antic T
    Acta Cytol; 2019; 63(5):438-444. PubMed ID: 31230044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignant rhabdoid tumors express stem cell factors, which relate to the expression of EZH2 and Id proteins.
    Venneti S; Le P; Martinez D; Xie SX; Sullivan LM; Rorke-Adams LB; Pawel B; Judkins AR
    Am J Surg Pathol; 2011 Oct; 35(10):1463-72. PubMed ID: 21921784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypical teratoid/ rhabdoid tumor, an immunohistochemical study of potential diagnostic and prognostic markers.
    Al-Hussaini M; Dissi N; Souki C; Amayiri N
    Neuropathology; 2016 Feb; 36(1):17-26. PubMed ID: 26207291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical Teratoid/ Rhabdoid Tumor of Brain: a Clinicopathologic Study of Eleven Patients and Review of Literature.
    Ud Din N; Barakzai A; Memon A; Hasan Sh; Ahmad Z
    Asian Pac J Cancer Prev; 2017 Apr; 18(4):949-954. PubMed ID: 28545192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical teratoid/rhabdoid tumor of the pineal region in an adult.
    Takei H; Adesina AM; Mehta V; Powell SZ; Langford LA
    J Neurosurg; 2010 Aug; 113(2):374-9. PubMed ID: 19911885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SMARCA4-Mutated Atypical Teratoid/Rhabdoid Tumor with Retained BRG1 Expression.
    Masliah-Planchon J; Machet MC; Fréneaux P; Jourdain A; Mortemousque I; Raïs KA; Ballet S; Jouvet A; Figarella-Branger D; Delattre O; Bourdeaut F
    Pediatr Blood Cancer; 2016 Mar; 63(3):568-9. PubMed ID: 26469284
    [No Abstract]   [Full Text] [Related]  

  • 39. An infantile pineal embryonal tumor showing pathological features of a CNS ganglioneuroblastoma and the methylation profiling of an atypical teratoid/rhabdoid tumor and SMARCA4 mutation.
    Fukuoka K; Nakazawa A; Hirato J; Nobusawa S; Itabashi T; Arakawa Y; Mori M; Matsushita Y; Honda S; Tanami Y; Ichimura K; Kurihara J; Koh K
    J Neuropathol Exp Neurol; 2023 Jun; 82(7):664-667. PubMed ID: 37086056
    [No Abstract]   [Full Text] [Related]  

  • 40. Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome.
    Frühwald MC; Hasselblatt M; Wirth S; Köhler G; Schneppenheim R; Subero JI; Siebert R; Kordes U; Jürgens H; Vormoor J
    Pediatr Blood Cancer; 2006 Sep; 47(3):273-8. PubMed ID: 16206192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.